Mycophenolate Mofetil (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Mycophenolate Mofetil drug offered from Cadila Healthcare Limited. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | Mycophenolate Mofetil |
| SUBSTANCE NAME: | MYCOPHENOLATE MOFETIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-22 |
| END MARKETING DATE: | 0000-00-00 |
Mycophenolate Mofetil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Mycophenolate Mofetil from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/20mL) |
| START MARKETING DATE: | 2017-09-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1084_f53d29cf-87b2-49b2-8050-b4a4223a8273 |
| PRODUCT NDC: | 70771-1084 |
| APPLICATION NUMBER: | ANDA204473 |
Other MYCOPHENOLATE MOFETIL Pharmaceutical Manufacturers / Labelers:
